Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
CRVS
CRVS News & Events
-
Add to Watchlist
Trade CRVS
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
CRVS News
Corvus' Oral Therapy Potential Underestimated by Analysts
1d ago
stocktwits
Goldman Sachs Initiates Buy on Corvus with $40 Target
1d ago
seekingalpha
Goldman Sachs Bullish on Corvus Pharmaceuticals Stock Outlook
1d ago
CNBC
Latest Ratings and Outlook from Wall Street
1d ago
CNBC
CORVUS PHARMACEUTICALS: OPPENHEIMER INCREASES TARGET PRICE TO $33, UP FROM $32
Mar 13 2026
moomoo
Corvus (CRVS) Q4 2025 Earnings Call Transcript
Mar 13 2026
NASDAQ.COM
Corvus Pharmaceuticals Q4 2025 Earnings Call Insights
Mar 13 2026
seekingalpha
Corvus Pharmaceuticals Q4 Earnings Miss Expectations
Mar 12 2026
seekingalpha
Show More News
CRVS Events
03/13 08:10
Corvus Pharmaceuticals Files Automatic Mixed Securities Shelf
Corvus Pharmaceuticals files automatic mixed securities shelf
Show More Events
CRVS Monitor News
Corvus Pharmaceuticals Prices $175M Upsized Public Offering
Jan 26 2026
Corvus Pharmaceuticals Reports Positive Trial Results and Upsizes Stock Offering
Jan 22 2026
Corvus Pharmaceuticals to Report Phase 1 Trial Results for Soquelitinib
Jan 20 2026
CRVS Earnings Analysis
No Data
People Also Watch
